SLS SELLAS Life Sciences Group, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

SELLAS Life Sciences Group, Inc. (SLS) - korporativ logo

SELLAS Life Sciences (SLS) patent himoyasidagi galinpepimut-S vaksinalarini yaratish orqali immuno-onkologiya sohasida biofarmatsevtika muhitini rivojlantirmoqda. Biznes leykemiya terapiyasi bilan birga, o'smalarga qarshi kurashish uchun peptid dori vositalarini joriy etishga tayanadi. GURU.Markets platformasidagi aksiyalar uchun ushbu narxlar grafigi 16.72 qiymatidagi narxlar dinamikasini aks ettiradi, biroq, kapitalning kritik darajada kamayishi sababli, kompaniyaning omon qolishi III bosqich sinovlari natijalariga bog'liq.

sellaslifesciences.com (SLS): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

SELLAS Life Sciences (SLS) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi sellaslifesciences.com|SLS - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi SELLAS Life Sciences Group Inc.|SLS - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar SELLAS Life Sciences|SLS - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati sellaslifesciences.com|SLS - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati SELLAS Life Sciences|SLS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati sellaslifesciences.com|SLS - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati SELLAS Life Sciences Group Inc.
Kompaniyaning asosiy tahlili:SLS (SELLAS Life Sciences Group, Inc.)
sellaslifesciences.com brendining mahsuloti

Ushbu koeffitsiyent pozitsiyalarni stress-testidan o'tkazishda asosiy filtr vazifasini o'tab, biznesning moddiy aktivlariga nisbatan haddan tashqari yuqori baholanganlik darajasini aniqlaydi. Kompaniyaning bozor qiymatining uning balans aktivlariga nisbatini tahlil qilish orqali investor rahbariyatning qo'shimcha qiymat yaratish qobiliyatini baholaydi, bu esa SELLAS Life Sciences (SLS) uchun peptid sintezini robotlashtirish samaradorligi va onkologik dori vositalarini ishlab chiqishni tezlashtirishga bevosita bog'liqdir.

Raqobatchilar tahlili

ONC (BeiGene Ltd) - Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Kapitallashuvning sof aktivlarga nisbati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AAPG|Bozor qiymatining balans qiymatiga nisbati CG Oncology Corp CGON|Kapitallashuvning balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bicara Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati personalis.com PSNL|ERAS (Erasca) - Bozor kapitallashuvining balans qiymatiga nisbati|DCTH: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati YmAbs YMAB|Balans qiymatiga nisbatan bozor qiymati Aura Corp|CADL - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com|Bozor kapitallashuvining balans qiymatiga nisbati ACTU (Actuate Therapeutics)|Kapitallashuvning sof aktivlarga nisbati Citius Oncology Inc. CTOR|Kapitallashuvning sof aktivlarga nisbati HURA (TuHURA Biosciences)|Protara Tx - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Fate Therapeutics, Inc. (FATE)|WHWK - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TCRX|CSBR (Champions Oncology, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|XBIT: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CEL-SCI Corp|OS Therapies Incorporated - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti RADX (Radiopharm Theranostics Ltd)|Bozor qiymatining balans qiymatiga nisbati Artiva Biotherapeutics ARTV|Adlai Nortye Ltd - Bozor qiymatining balans qiymatiga nisbati|VERU - Bozor qiymatining balans qiymatiga nisbati|TPST - Bozor qiymatining balans qiymatiga nisbati|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|RENB (Renovaro) - Bozor kapitallashuvining balans qiymatiga nisbati|MURA: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Kairos Pharma Inc (KAPA)|OnKure Therapeutics Inc (OKUR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati GDTC (w2.cytomed.sg)|Bozor qiymatining balans qiymatiga nisbati Curis CRIS|Bozor qiymatining balans qiymatiga nisbati Apollomics Inc. APLM|Bozor kapitallashuvining balans qiymatiga nisbati THAR (Tharimmune)|ADVB - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Genprex, Inc (GNPX)|Calidi Biotherapeutics, Inc. (CLDI) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SBFM (Sunshine Biopharma)|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenetic Bio (XBIO)|Salarius Pharmaceuticals, Inc. (SLRX) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati PPBT (Purple Biotech Ltd)|Bozor qiymatining balans qiymatiga nisbati AONC|Balans qiymatiga nisbatan bozor kapitallashuvi BeiGene Ltd BGNE|CKPT: Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Kapitallashuvning sof aktivlarga nisbati|icadmed.com - Bozor kapitallashuvining balans qiymatiga nisbati|Ikena Oncology (IKNA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NTBL (Notable Labs Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti VIRX|Bozor qiymatining balans qiymatiga nisbati MorphoSys AG MOR|Kapitallashuvning balans qiymatiga nisbati nayabiosciences.com (NAYA)|Ascentage Pharma - Bozor kapitallashuvining balans qiymatiga nisbati